交易 BridgeBio Pharma, Inc. - BBIO CFD
新增到我的最愛- 摘要
- 曆史數據
- 活動
- 盈虧控制
- 資産負債表
- 現金流
交易條件
價差 | 0.12 | ||||||||
多頭倉位隔夜費用
多頭隔夜費用
前往平台 | -0.026179% | ||||||||
空頭倉位隔夜費用
空頭隔夜費用
前往平台 | 0.003957% | ||||||||
隔夜費時間 | 21:00 (UTC) | ||||||||
最小成交量 | 1 | ||||||||
貨幣 | USD | ||||||||
保證金 | 5% | ||||||||
股票交易 | United States of America | ||||||||
交易委員會 | 0% |
*Information provided by Capital.com
BridgeBio Pharma Inc ESG Risk Ratings
High Medium Low Negligible
“C”分數表示在公開報告重大 ESG 數據方面令人滿意的相對 ESG 表現和適度的透明度。
- 上週
- 上個月
- 去年
- 過去兩年
- 最大
- 每日
- 每週
- 每月
日期 | 拋售 | 自訂 | 變化 (%) | 打開 | 最高 | 最小 |
---|---|---|---|---|---|---|
Apr 22, 2024 | 25.01 | 0.12 | 0.48% | 24.89 | 25.46 | 24.07 |
Apr 19, 2024 | 24.68 | -0.04 | -0.16% | 24.72 | 25.23 | 24.22 |
Apr 18, 2024 | 24.91 | 0.15 | 0.61% | 24.76 | 25.46 | 24.70 |
Apr 17, 2024 | 24.93 | -0.35 | -1.38% | 25.28 | 25.56 | 24.69 |
Apr 16, 2024 | 25.21 | -0.04 | -0.16% | 25.25 | 25.86 | 25.14 |
Apr 15, 2024 | 25.73 | -0.74 | -2.80% | 26.47 | 26.61 | 25.64 |
Apr 12, 2024 | 26.78 | -0.85 | -3.08% | 27.63 | 27.91 | 26.31 |
Apr 11, 2024 | 28.32 | 1.02 | 3.74% | 27.30 | 28.70 | 26.80 |
Apr 10, 2024 | 27.26 | 0.21 | 0.78% | 27.05 | 27.43 | 26.67 |
Apr 9, 2024 | 28.40 | 0.18 | 0.64% | 28.22 | 28.58 | 27.75 |
Apr 8, 2024 | 28.22 | -0.04 | -0.14% | 28.26 | 28.39 | 27.78 |
Apr 5, 2024 | 28.07 | 0.17 | 0.61% | 27.90 | 28.70 | 27.57 |
Apr 4, 2024 | 28.10 | -1.20 | -4.10% | 29.30 | 29.50 | 28.05 |
Apr 3, 2024 | 29.17 | 0.92 | 3.26% | 28.25 | 29.26 | 28.18 |
Apr 2, 2024 | 28.75 | -0.53 | -1.81% | 29.28 | 29.29 | 28.52 |
Apr 1, 2024 | 29.92 | -0.78 | -2.54% | 30.70 | 30.70 | 29.60 |
Mar 28, 2024 | 30.84 | 0.12 | 0.39% | 30.72 | 31.12 | 30.29 |
Mar 27, 2024 | 30.81 | 0.49 | 1.62% | 30.32 | 31.16 | 29.55 |
Mar 26, 2024 | 29.69 | 0.29 | 0.99% | 29.40 | 30.22 | 28.83 |
Mar 25, 2024 | 29.34 | 0.03 | 0.10% | 29.31 | 29.60 | 28.90 |
BridgeBio Pharma, Inc. Events
時間 (UTC) | 國家 | 事件 |
---|---|---|
Thursday, May 2, 2024 | ||
時間 (UTC) 12:30 | 國家 US
| 事件 Q1 2024 BridgeBio Pharma Inc Earnings Release Q1 2024 BridgeBio Pharma Inc Earnings ReleaseForecast(預報) -返回 - |
Thursday, June 20, 2024 | ||
時間 (UTC) 16:00 | 國家 US
| 事件 BridgeBio Pharma Inc Annual Shareholders Meeting BridgeBio Pharma Inc Annual Shareholders MeetingForecast(預報) -返回 - |
Thursday, August 1, 2024 | ||
時間 (UTC) 12:30 | 國家 US
| 事件 Q2 2024 BridgeBio Pharma Inc Earnings Release Q2 2024 BridgeBio Pharma Inc Earnings ReleaseForecast(預報) -返回 - |
- 每年
- 每季度
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
總收入 | 77.648 | 69.716 | 8.249 | 40.56 | 0 |
收入 | 77.648 | 69.716 | 8.249 | 40.56 | 0 |
收入成本,共計 | 3.434 | 3.114 | 0 | 2.5 | 0 |
毛利 | 74.214 | 66.602 | 8.249 | 38.06 | 0 |
總營業費用 | 589.85 | 646.348 | 482.731 | 307.216 | 164.333 |
銷售/一般/行政費用,總計 | 143.189 | 192.21 | 145.684 | 94.353 | 43.587 |
研究與開發 | 399.462 | 451.024 | 337.047 | 207.947 | 140.073 |
異常費用(收入) | 43.765 | 2.416 | -19.327 | ||
營業收入 | -512.202 | -576.632 | -474.482 | -266.656 | -164.333 |
利息收入(費用),非經營淨值 | 35.05 | -45.645 | -32.64 | -20.719 | -0.818 |
其他,淨值 | -7.5 | 35.823 | 1.634 | -1.21 | -4.3 |
稅前淨收入 | -484.652 | -586.454 | -505.488 | -288.585 | -169.451 |
稅後淨收入 | -484.652 | -586.454 | -505.488 | -288.585 | -169.451 |
少數股東權益 | 3.469 | 23.915 | 56.764 | 27.998 | 38.702 |
未計算非常項目前的淨收益 | -481.183 | -562.539 | -448.724 | -260.587 | -130.749 |
淨收入 | -481.183 | -562.539 | -448.724 | -260.587 | -130.749 |
普通股股東可獲收益 (不含非經常性項目) | -481.183 | -562.539 | -448.724 | -260.587 | -130.749 |
普通股股東可獲收益 (含非經常性項目) | -481.183 | -562.539 | -448.724 | -260.587 | -130.749 |
攤薄淨收入 | -481.183 | -562.539 | -448.724 | -260.587 | -130.749 |
攤薄後加權平均股 | 147.473 | 144.357 | 117.995 | 105.099 | 115 |
扣除特別項目的每股攤薄盈利 | -3.26285 | -3.89687 | -3.80289 | -2.47944 | -1.13695 |
Dividends per Share - Common Stock Primary Issue | 0 | ||||
每股正常攤薄盈利 | -2.96609 | -3.89687 | -3.80289 | -2.45645 | -1.30501 |
Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | |
---|---|---|---|---|---|
總收入 | 1.641 | 1.826 | 1.87 | 0.338 | 73.746 |
收入 | 1.641 | 1.826 | 1.87 | 0.338 | 73.746 |
總營業費用 | 147.74 | 127.989 | 131.102 | 129.454 | 153.922 |
銷售/一般/行政費用,總計 | 36.122 | 31.108 | 31.862 | 31.188 | 36.426 |
研究與開發 | 107.488 | 92.861 | 90.902 | 92.511 | 108.4 |
營業收入 | -146.099 | -126.163 | -129.232 | -129.116 | -80.176 |
利息收入(費用),非經營淨值 | -14.645 | -15.004 | -15.898 | -17.408 | 88.433 |
其他,淨值 | 0.041 | -1.565 | 4.56 | 6.331 | -10.816 |
稅前淨收入 | -160.703 | -142.732 | -140.57 | -140.193 | -2.559 |
稅後淨收入 | -160.703 | -142.732 | -140.57 | -140.193 | -2.559 |
少數股東權益 | 2.804 | 2.576 | 2.979 | 2.854 | -7.297 |
未計算非常項目前的淨收益 | -157.899 | -140.156 | -137.591 | -137.339 | -9.856 |
淨收入 | -157.899 | -140.156 | -137.591 | -137.339 | -9.856 |
普通股股東可獲收益 (不含非經常性項目) | -157.899 | -140.156 | -137.591 | -137.339 | -9.856 |
普通股股東可獲收益 (含非經常性項目) | -157.899 | -140.156 | -137.591 | -137.339 | -9.856 |
攤薄淨收入 | -157.899 | -140.156 | -137.591 | -137.339 | -9.856 |
攤薄後加權平均股 | 160.535 | 152.646 | 149.365 | 147.938 | 146.685 |
扣除特別項目的每股攤薄盈利 | -0.98358 | -0.91818 | -0.92117 | -0.92836 | -0.06719 |
Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | 0 | |
每股正常攤薄盈利 | -0.96158 | -0.89611 | -0.86968 | -0.89445 | -0.00995 |
收入成本,共計 | 0.599 | 0.651 | 0.647 | 0.739 | 0.7 |
毛利 | 1.042 | 1.175 | 1.223 | -0.401 | 73.046 |
異常費用(收入) | 3.531 | 3.369 | 7.691 | 5.016 | 8.396 |
- 每年
- 每季度
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
流動資産總額 | 548.853 | 888.858 | 642.824 | 568.622 | 445.223 |
現金和短期投資 | 471.922 | 836.663 | 607.093 | 545.993 | 436.086 |
現金等價物 | 376.689 | 393.772 | 356.082 | 363.773 | 436.086 |
預付的費用 | 21.922 | 32.269 | 35.592 | 22.629 | 7.087 |
其他流動資産,總計 | 55.009 | 19.926 | 0.139 | 2.05 | |
總資産 | 623.036 | 1012.79 | 703.588 | 631.679 | 464.941 |
物業/廠房/設備,總計 - 淨額 | 25.247 | 45.973 | 36.833 | 5.625 | 1.575 |
物業/廠房/設備,總計 - 總額 | 1.806 | ||||
累計折舊,總計 | -0.231 | ||||
長期投資 | 31.144 | 17.05 | |||
其他長期資産,總計 | 20.224 | 33.027 | 23.931 | 26.288 | 1.093 |
流動負債總額 | 121.428 | 135.069 | 95.648 | 60.385 | 32.577 |
應付賬款 | 11.558 | 11.884 | 8.945 | 8.852 | 13.509 |
預提費用 | 101.714 | 122.89 | 79.567 | 47.455 | 15.062 |
應付票據/短期債務 | 0 | 0 | 0 | 0 | 0 |
其他流動負債,總計 | 8.156 | 0 | 5.55 | 4.078 | 4.006 |
負債總額 | 1877.65 | 1883.21 | 645.682 | 223.225 | 150.062 |
長期債務總額 | 1707.61 | 1705.05 | 477.43 | 91.791 | 54.507 |
長期債務 | 1707.61 | 1703.81 | 475.857 | 91.791 | 54.507 |
少數股權 | 9.693 | 4.835 | 49.98 | 67.522 | 62.483 |
其他負債,總計 | 38.917 | 38.252 | 22.624 | 3.527 | 0.495 |
股權 | -1254.62 | -870.414 | 57.906 | 408.454 | 314.879 |
Preferred Stock - Non Redeemable, Net | 478.865 | ||||
普通股 | 0.157 | 0.154 | 0.125 | 0.124 | 3.373 |
留存收益(累計赤字) | -1918.15 | -1436.97 | -888.755 | -440.031 | -167.359 |
總負債和股東權益 | 623.036 | 1012.79 | 703.588 | 631.679 | 464.941 |
已發行普通股總數 | 150.626 | 147.343 | 122.849 | 123.658 | 115 |
短期投資 | 95.233 | 442.891 | 251.011 | 182.22 | |
Redeemable Preferred Stock | 0 | ||||
額外實收資本 | 938.703 | 841.53 | 1021.34 | 848.107 | |
其他權益,總計 | -0.328 | -0.132 | 0.192 | 0.254 | |
長期債務的當前部分/資本租賃 | 0.295 | 1.586 | |||
資本租賃義務 | 1.245 | 1.573 | |||
Treasury Stock - Common | -275 | -275 | -75 | ||
無形資産,淨額 | 28.712 | 44.934 |
Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | |
---|---|---|---|---|---|
流動資産總額 | 587.67 | 432.884 | 552.702 | 548.853 | 642.219 |
現金和短期投資 | 543.265 | 383.794 | 491.293 | 471.922 | 591.977 |
現金等價物 | 505.213 | 302.438 | 407.368 | 376.689 | 483.235 |
短期投資 | 38.052 | 81.356 | 83.925 | 95.233 | 108.742 |
應收賬款總額,淨額 | |||||
預付的費用 | 22.583 | 20.546 | 25.145 | 21.922 | 25.521 |
總資産 | 655.008 | 503.661 | 625.68 | 623.036 | 728.74 |
物業/廠房/設備,總計 - 淨額 | 21.745 | 22.861 | 24.098 | 25.247 | 27.341 |
長期投資 | |||||
其他長期資産,總計 | 18.676 | 20.401 | 20.767 | 20.224 | 29.87 |
流動負債總額 | 106.065 | 110.12 | 96.596 | 121.428 | 119.194 |
應付賬款 | 4.472 | 3.874 | 4.076 | 11.558 | 10.158 |
預提費用 | 95.001 | 100.036 | 85.845 | 101.714 | 101.518 |
應付票據/短期債務 | 0 | 0 | 0 | 0 | 0 |
長期債務的當前部分/資本租賃 | |||||
其他流動負債,總計 | 6.592 | 6.21 | 6.675 | 8.156 | 7.518 |
負債總額 | 1862.55 | 1865.68 | 1851.34 | 1877.65 | 1867.16 |
長期債務總額 | 1721.08 | 1718.94 | 1713.29 | 1707.61 | 1698.69 |
長期債務 | 1721.08 | 1718.94 | 1713.29 | 1707.61 | 1698.69 |
資本租賃義務 | |||||
少數股權 | 13.808 | 12.385 | 12.052 | 9.693 | 8.044 |
其他負債,總計 | 21.597 | 24.242 | 29.405 | 38.917 | 41.226 |
股權 | -1207.54 | -1362.02 | -1225.67 | -1254.62 | -1138.42 |
普通股 | 0.18 | 0.168 | 0.167 | 0.157 | 0.156 |
額外實收資本 | 1459.6 | 1128.1 | 1106.64 | 938.703 | 917.333 |
留存收益(累計赤字) | -2392.35 | -2215.35 | -2057.46 | -1918.15 | -1780.56 |
Treasury Stock - Common | -275 | -275 | -275 | -275 | -275 |
其他權益,總計 | 0.034 | 0.063 | -0.012 | -0.328 | -0.348 |
總負債和股東權益 | 655.008 | 503.661 | 625.68 | 623.036 | 728.74 |
已發行普通股總數 | 174.132 | 161.42 | 160.435 | 150.626 | 149.367 |
應收賬款 - 貿易,淨額 | |||||
其他流動資産,總計 | 21.822 | 28.544 | 36.264 | 55.009 | 24.721 |
Redeemable Preferred Stock | 0 | 0 | 0 | 0 | |
無形資産,淨額 | 26.917 | 27.515 | 28.113 | 28.712 | 29.31 |
- 每年
- 每季度
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
淨收入/起跑線 | -484.652 | -586.454 | -505.488 | -288.585 | -169.451 |
經營活動産生的現金 | -419.494 | -497.934 | -399.714 | -253.587 | -136.643 |
經營活動産生的現金 | 6.771 | 5.843 | 0.245 | ||
非現金物品 | 24.047 | 83.736 | 90.84 | 45.913 | 10.072 |
已付現金利息 | 54.443 | 29.774 | 15.322 | 6.092 | 1.574 |
營運資金的變化 | 34.34 | -1.059 | 14.934 | -10.915 | 22.491 |
投資活動産生的現金 | 453.147 | -200.826 | -52.993 | -217.253 | -21.036 |
資本支出 | -6.321 | -13.246 | -7.518 | -5.138 | -18.178 |
其他投資現金流量項目,總計 | 459.468 | -187.58 | -45.475 | -212.115 | -2.858 |
融資活動産生的現金 | -13.134 | 736.446 | 447.189 | 398.792 | 501.548 |
融資現金流項目 | -0.724 | -163.695 | -41.939 | -7.272 | 14.196 |
股票的發行(報廢),淨額 | 8.076 | -179.536 | -60.872 | 368.946 | 430.974 |
債務的發行(退還),淨額 | -20.486 | 1079.68 | 550 | 37.118 | 56.378 |
現金淨變化 | 20.519 | 37.686 | -5.518 | -72.048 | 343.869 |
Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
---|---|---|---|---|---|
Net income/Starting Line | -142.732 | -484.652 | -344.082 | -203.889 | -201.33 |
Cash From Operating Activities | -144.322 | -419.494 | -326.251 | -191.088 | -160.635 |
Non-Cash Items | 28.579 | 24.047 | -9.872 | -20.128 | 42.625 |
Cash Interest Paid | 22.059 | 54.443 | 47.575 | 25.435 | 18.809 |
Changes in Working Capital | -31.802 | 34.34 | 22.592 | 29.463 | -3.814 |
Cash From Investing Activities | 12.298 | 453.147 | 435.182 | 288.325 | 138.623 |
Capital Expenditures | -0.012 | -6.321 | -5.52 | -4.761 | -0.859 |
Other Investing Cash Flow Items, Total | 12.31 | 459.468 | 440.702 | 293.086 | 139.482 |
Cash From Financing Activities | 150.249 | -13.134 | -19.511 | -20.956 | -0.16 |
Financing Cash Flow Items | 5.231 | -0.724 | -2.192 | -1.596 | -1.23 |
Issuance (Retirement) of Stock, Net | 145.018 | 8.076 | 3.167 | 1.126 | 1.07 |
Issuance (Retirement) of Debt, Net | -20.486 | -20.486 | -20.486 | 0 | |
Net Change in Cash | 18.225 | 20.519 | 89.42 | 76.281 | -22.172 |
Cash From Operating Activities | 1.633 | 6.771 | 5.111 | 3.466 | 1.884 |
差價合約交易計算器
計算您的假設損益
交易佣金
0
- 1:1
槓桿
1:1
- 20
- 100
- 500
- 1000
- 10000
交易
交易規模(槓桿 x 投資):
打開
拋售
已賣出 做多
Industry: | Biopharmaceuticals |
3160 Porter Dr.
Suite 250
PALO ALTO
CALIFORNIA 94304
US
盈虧控制
- Annual
- Quarterly
人們也觀看
還在尋找值得信賴的經紀商?
加入全球 610,000 多名交易者,選擇與 Capital.com 交易